Raras
Buscar doenças, sintomas, genes...
Disgenesia gonadal completa 46,XY
ORPHA:242CID-10 · Q99.1CID-11 · LD2A.1DOENÇA RARA

A disgenesia gonadal completa 46,XY (46,XY CGD) é um distúrbio do desenvolvimento sexual (DDS) associado a anomalias no desenvolvimento gonadal que resultam na presença de genitália externa e interna feminina, apesar do cariótipo 46,XY.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A disgenesia gonadal completa 46,XY (46,XY CGD) é um distúrbio do desenvolvimento sexual (DDS) associado a anomalias no desenvolvimento gonadal que resultam na presença de genitália externa e interna feminina, apesar do cariótipo 46,XY.

Publicações científicas
52 artigos
Último publicado: 2025 Nov 28

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adolescent
+ adult
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q99.1
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

📏
Crescimento
10 sintomas
😀
Face
7 sintomas
🧠
Neurológico
5 sintomas
🦴
Ossos e articulações
3 sintomas
👂
Ouvidos
2 sintomas
💪
Músculos
2 sintomas

+ 65 sintomas em outras categorias

Características mais comuns

90%prev.
Testículos displásicos
Muito frequente (99-80%)
90%prev.
Disgenesia testicular
90%prev.
Ovários policísticos
Muito frequente (99-80%)
90%prev.
Pseudo-hermafroditismo masculino
Muito frequente (99-80%)
90%prev.
Hipogonadismo hipogonadotrófico
Muito frequente (99-80%)
Disgenesia gonadal com aparência feminina, masculina
100sintomas
Muito frequente (5)
Sem dados (95)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 100 características clínicas mais associadas, ordenadas por frequência.

Testículos displásicosDysplastic testes
Muito frequente (99-80%)90%
Disgenesia testicularTesticular dysgenesis
Muito frequente90%
Ovários policísticosPolycystic ovaries
Muito frequente (99-80%)90%
Pseudo-hermafroditismo masculinoMale pseudohermaphroditism
Muito frequente (99-80%)90%
Hipogonadismo hipogonadotróficoHypogonadotropic hypogonadism
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico52PubMed
Últimos 10 anos4publicações
Pico20171 papers
Linha do tempo
2026Hoje · 2026🧪 2021Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

13 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, X-linked recessive, Y-linked.

DHHDesert hedgehog proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

The C-terminal part of the desert hedgehog protein precursor displays an autoproteolysis and a cholesterol transferase activity (By similarity). Both activities result in the cleavage of the full-length protein into two parts (N-product and C-product) followed by the covalent attachment of a cholesterol moiety to the C-terminal of the newly generated N-product (DHH-N) (By similarity). Both activities occur in the endoplasmic reticulum (By similarity). Once cleaved, the C-product is degraded in t

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membraneGolgi apparatus membraneSecreted

VIAS BIOLÓGICAS (5)
Hedgehog 'on' stateActivation of SMOLigand-receptor interactionsRelease of Hh-Np from the secreting cellTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

46,XY gonadal dysgenesis with minifascicular neuropathy

An autosomal recessive disorder characterized by gonadal dysgenesis associated with polyneuropathy. Genital anomalies include the presence of a testis on one side and a streak or an absent gonad at the other, persistence of Muellerian duct structures, and a variable degree of genital ambiguity.

EXPRESSÃO TECIDUAL(Tecido-específico)
Nervo tibial
58.0 TPM
Testículo
39.0 TPM
Artéria coronária
1.8 TPM
Rim - Medula
1.2 TPM
Tecido adiposo
1.2 TPM
OUTRAS DOENÇAS (3)
46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome46,XY sex reversal 746,XY complete gonadal dysgenesis
HGNC:2865UniProt:O43323
AKR1C4Aldo-keto reductase family 1 member C4Candidate gene tested inTolerante
FUNÇÃO

Cytosolic aldo-keto reductase that catalyzes NADPH-dependent reduction of ketosteroids to hydroxysteroids. Displays broad substrate specificity with distinct positional and stereochemistry, primarily generating 3alpha/beta-, 17beta- and 20alpha-hydroxysteroids (PubMed:10634139, PubMed:10998348, PubMed:11158055, PubMed:14672942, PubMed:1530633, PubMed:12604236, PubMed:19218247, PubMed:21802064, PubMed:7650035). Required for male sex determination as a component of the 'backdoor' androgen biosynth

LOCALIZAÇÃO

Cytoplasm, cytosol

VIAS BIOLÓGICAS (4)
Synthesis of bile acids and bile salts via 24-hydroxycholesterolSynthesis of bile acids and bile salts via 7alpha-hydroxycholesterolSynthesis of bile acids and bile salts via 27-hydroxycholesterolRetinoid metabolism and transport
MECANISMO DE DOENÇA

46,XY sex reversal 8

A disorder of sex development. Affected individuals have a 46,XY karyotype but present as phenotypically normal females.

OUTRAS DOENÇAS (1)
46,XY disorder of sex development due to testicular 17,20-desmolase deficiency
HGNC:387UniProt:P17516
AKR1C2Aldo-keto reductase family 1 member C2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Cytosolic aldo-keto reductase that catalyzes NADPH-dependent reduction of ketosteroids to hydroxysteroids. Displays broad substrate specificity with distinct positional and stereochemistry, primarily generating 3alpha-hydroxysteroids, but also 3beta-, 17beta- and 20alpha-hydroxysteroids (PubMed:8920937, PubMed:9716498, PubMed:10998348, PubMed:12416991, PubMed:11995921, PubMed:12604236, PubMed:14672942, PubMed:19218247, PubMed:21802064, PubMed:11514561, PubMed:15929998, PubMed:17034817, PubMed:17

LOCALIZAÇÃO

Cytoplasm, cytosol

VIAS BIOLÓGICAS (3)
Synthesis of bile acids and bile salts via 24-hydroxycholesterolSynthesis of bile acids and bile salts via 7alpha-hydroxycholesterolSynthesis of bile acids and bile salts via 27-hydroxycholesterol
MECANISMO DE DOENÇA

46,XY sex reversal 8

A disorder of sex development. Affected individuals have a 46,XY karyotype but present as phenotypically normal females.

OUTRAS DOENÇAS (1)
46,XY disorder of sex development due to testicular 17,20-desmolase deficiency
HGNC:385UniProt:P52895
ZFPM2Zinc finger protein ZFPM2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription regulator that plays a central role in heart morphogenesis and development of coronary vessels from epicardium, by regulating genes that are essential during cardiogenesis. Essential cofactor that acts via the formation of a heterodimer with transcription factors of the GATA family GATA4, GATA5 and GATA6. Such heterodimer can both activate or repress transcriptional activity, depending on the cell and promoter context. Also required in gonadal differentiation, possibly be regulatin

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Transcriptional regulation of testis differentiationFactors involved in megakaryocyte development and platelet production
MECANISMO DE DOENÇA

Tetralogy of Fallot

A congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing cyanosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
39.2 TPM
Cerebelo
27.3 TPM
Ovário
27.0 TPM
Fallopian Tube
17.6 TPM
Útero
16.3 TPM
OUTRAS DOENÇAS (5)
tetralogy of fallot46,XY sex reversal 9diaphragmatic hernia 3congenital diaphragmatic hernia
HGNC:16700UniProt:Q8WW38
NR5A1Steroidogenic factor 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional activator. Essential for sexual differentiation and formation of the primary steroidogenic tissues (PubMed:27378692). Binds to the Ad4 site found in the promoter region of steroidogenic P450 genes such as CYP11A, CYP11B and CYP21B. Also regulates the AMH/Muellerian inhibiting substance gene as well as the AHCH and STAR genes. 5'-YCAAGGYC-3' and 5'-RRAGGTCA-3' are the consensus sequences for the recognition by NR5A1 (PubMed:27378692). The SFPQ-NONO-NR5A1 complex binds to the CYP17

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (4)
Transcriptional regulation of pluripotent stem cellsNuclear Receptor transcription pathwayTranscriptional regulation of testis differentiationSUMOylation of intracellular receptors
MECANISMO DE DOENÇA

46,XY sex reversal 3

A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype.

EXPRESSÃO TECIDUAL(Tecido-específico)
Baço
221.6 TPM
Glândula adrenal
216.7 TPM
Ovário
74.6 TPM
Pituitária
33.4 TPM
Testículo
31.2 TPM
OUTRAS DOENÇAS (10)
spermatogenic failure 8premature ovarian failure 746,XX sex reversal 446,XY sex reversal 3
HGNC:7983UniProt:Q13285
MAP3K1Mitogen-activated protein kinase kinase kinase 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of a protein kinase signal transduction cascade (PubMed:9808624). Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4 (PubMed:9808624). May phosphorylate the MAPK8/JNK1 kinase (PubMed:17761173). Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway (PubMed:9808624)

LOCALIZAÇÃO

VIAS BIOLÓGICAS (5)
FCERI mediated MAPK activationTRAF6 mediated NF-kB activationMyD88:MAL(TIRAP) cascade initiated on plasma membraneTRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activationMyD88 cascade initiated on plasma membrane
MECANISMO DE DOENÇA

46,XY sex reversal 6

A disorder of sex development. Affected individuals have a 46,XY karyotype but present as phenotypically normal females.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
37.2 TPM
Skin Sun Exposed Lower leg
36.7 TPM
Tireoide
29.7 TPM
Baço
26.1 TPM
Vagina
21.2 TPM
OUTRAS DOENÇAS (3)
46,XY sex reversal 646,XY partial gonadal dysgenesis46,XY complete gonadal dysgenesis
HGNC:6848UniProt:Q13233
DHX37Probable ATP-dependent RNA helicase DHX37Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

ATP-binding RNA helicase that plays a role in maturation of the small ribosomal subunit in ribosome biogenesis (PubMed:30582406). Required for the release of the U3 snoRNP from pre-ribosomal particles (PubMed:30582406). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and wor

LOCALIZAÇÃO

Nucleus, nucleolusCytoplasmNucleus membrane

VIAS BIOLÓGICAS (2)
rRNA modification in the nucleus and cytosolMajor pathway of rRNA processing in the nucleolus and cytosol
MECANISMO DE DOENÇA

Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies

An autosomal recessive neurodevelopmental disorder characterized by severe developmental delay, impaired intellectual development, hypotonia, brain anomalies including cortical volume loss, corpus callosum dysgenesis and cerebellar hypoplasia, and variable dysmorphic features. Patients may have platyspondyly, scoliosis, and cardiac anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
34.9 TPM
Fibroblastos
19.3 TPM
Ovário
19.0 TPM
Útero
18.1 TPM
Nervo tibial
17.0 TPM
OUTRAS DOENÇAS (4)
neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies46,XY sex reversal 1146,XY complete gonadal dysgenesis46,XY partial gonadal dysgenesis
HGNC:17210UniProt:Q8IY37
CBX2Chromobox protein homolog 2Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development (PubMed:21282530). PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:21282530). Binds to histone H3 trimethylated at 'Lys-9' (H3K9me3) or at 'Lys

LOCALIZAÇÃO

NucleusChromosome

VIAS BIOLÓGICAS (8)
Regulation of PTEN gene transcriptionOxidative Stress Induced SenescenceRUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not knownSUMOylation of chromatin organization proteinsSUMOylation of DNA methylation proteins
MECANISMO DE DOENÇA

46,XY sex reversal 5

A disorder of sex development. Affected individuals have a 46,XY karyotype but present as phenotypically normal females.

OUTRAS DOENÇAS (2)
46,XY sex reversal 546,XY complete gonadal dysgenesis
HGNC:1552UniProt:Q14781
WT1Wilms tumor proteinCandidate gene tested inAltamente restrito
FUNÇÃO

Transcription factor that plays an important role in cellular development and cell survival (PubMed:7862533). Recognizes and binds to the DNA sequence 5'-GCG(T/G)GGGCG-3' (PubMed:17716689, PubMed:25258363, PubMed:7862533). Regulates the expression of numerous target genes, including EPO. Plays an essential role for development of the urogenital system. It has a tumor suppressor as well as an oncogenic role in tumor formation. Function may be isoform-specific: isoforms lacking the KTS motif may a

LOCALIZAÇÃO

NucleusNucleus, nucleolusCytoplasmNucleus speckleNucleus, nucleoplasm

VIAS BIOLÓGICAS (3)
Nephron developmentNegative Regulation of CDH1 Gene TranscriptionTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

Frasier syndrome

Characterized by a slowly progressing nephropathy leading to renal failure in adolescence or early adulthood, male pseudohermaphroditism, and no Wilms tumor. As for histological findings of the kidneys, focal glomerular sclerosis is often observed. There is phenotypic overlap with Denys-Drash syndrome. Inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Útero
109.7 TPM
Fallopian Tube
75.2 TPM
Ovário
65.2 TPM
Testículo
40.5 TPM
Adipose Visceral Omentum
30.0 TPM
OUTRAS DOENÇAS (12)
Wilms tumor 1nephrotic syndrome, type 4Meacham syndromemalignant mesothelioma
HGNC:12796UniProt:P19544
DMRT1Doublesex- and mab-3-related transcription factor 1Role in the phenotype ofAltamente restrito
FUNÇÃO

Transcription factor that plays a key role in male sex determination and differentiation by controlling testis development and male germ cell proliferation. Plays a central role in spermatogonia by inhibiting meiosis in undifferentiated spermatogonia and promoting mitosis, leading to spermatogonial development and allowing abundant and continuous production of sperm. Acts both as a transcription repressor and activator: prevents meiosis by restricting retinoic acid (RA)-dependent transcription a

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Transcriptional regulation of testis differentiation
MECANISMO DE DOENÇA

Testicular germ cell tumor

A common malignancy in males representing 95% of all testicular neoplasms. TGCTs have various pathologic subtypes including: unclassified intratubular germ cell neoplasia, seminoma (including cases with syncytiotrophoblastic cells), spermatocytic seminoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, and teratoma.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
45.4 TPM
Tireoide
0.3 TPM
Pituitária
0.0 TPM
Hipocampo
0.0 TPM
Linfócitos
0.0 TPM
OUTRAS DOENÇAS (1)
46,XY complete gonadal dysgenesis
HGNC:2934UniProt:Q9Y5R6
SOX9Transcription factor SOX-9Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription factor that plays a key role in chondrocytes differentiation and skeletal development (PubMed:24038782). Specifically binds the 5'-ACAAAG-3' DNA motif present in enhancers and super-enhancers and promotes expression of genes important for chondrogenesis, including cartilage matrix protein-coding genes COL2A1, COL4A2, COL9A1, COL11A2 and ACAN, SOX5 and SOX6 (PubMed:8640233). Also binds to some promoter regions (By similarity). Plays a central role in successive steps of chondrocyte

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (7)
Deactivation of the beta-catenin transactivating complexTranscriptional regulation by RUNX2Transcriptional regulation of testis differentiationTranscriptional and post-translational regulation of MITF-M expression and activityDevelopmental Lineage of Multipotent Pancreatic Progenitor Cells
MECANISMO DE DOENÇA

Campomelic dysplasia

A rare, often lethal, osteochondrodysplasia characterized by congenital bowing and angulation of long bones. Other skeletal defects include unusually small scapula, deformed pelvis and spine, and a missing pair of ribs. Craniofacial and ear defects are common. Most patients die soon after birth due to respiratory distress which has been attributed to hypoplasia of the tracheobronchial cartilage and small thoracic cage. Up to two-thirds of affected XY individuals have genital defects or may develop as phenotypic females.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula salivar
110.7 TPM
Testículo
66.8 TPM
Brain Caudate basal ganglia
47.5 TPM
Cérebro - Amígdala
42.6 TPM
Córtex cerebral
42.6 TPM
OUTRAS DOENÇAS (8)
campomelic dysplasia46,XX sex reversal 246,XY sex reversal 1046,XY complete gonadal dysgenesis
HGNC:11204UniProt:P48436
SRYSex-determining region Y proteinDisease-causing germline mutation(s) (loss of function) inDesconhecido
FUNÇÃO

Transcriptional regulator that controls a genetic switch in male development (PubMed:11563911). It is necessary and sufficient for initiating male sex determination by directing the development of supporting cell precursors (pre-Sertoli cells) as Sertoli rather than granulosa cells (PubMed:16414182, PubMed:16996051). Involved in different aspects of gene regulation including promoter activation or repression (PubMed:9525897). Binds to the DNA consensus sequence 5'-[AT]AACAA[AT]-3' (PubMed:115639

LOCALIZAÇÃO

Nucleus speckleCytoplasmNucleus

VIAS BIOLÓGICAS (2)
Deactivation of the beta-catenin transactivating complexTranscriptional regulation of testis differentiation
MECANISMO DE DOENÇA

46,XY sex reversal 1

A condition characterized by male-to-female sex reversal in the presence of a normal 46,XY karyotype. Patients manifest rapid and early degeneration of their gonads, which are present in the adult as 'streak gonads', consisting mainly of fibrous tissue and variable amounts of ovarian stroma. As a result these patients do not develop secondary sexual characteristics at puberty. The external genitalia in these subjects are completely female, and Muellerian structures are normal.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
4.5 TPM
Skin Sun Exposed Lower leg
3.4 TPM
Skin Not Sun Exposed Suprapubic
3.1 TPM
Fibroblastos
1.6 TPM
Esôfago - Mucosa
0.8 TPM
OUTRAS DOENÇAS (6)
46,XY sex reversal 145,X/46,XY mixed gonadal dysgenesis46,XY complete gonadal dysgenesis46,XX ovotesticular disorder of sex development
HGNC:11311UniProt:Q05066
NR0B1Nuclear receptor subfamily 0 group B member 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Nuclear receptor that lacks a DNA-binding domain and acts as a corepressor that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions (PubMed:12482977, PubMed:32433991). Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis (PubMed:7990953, PubMed:8675564). May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity)

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
Nuclear Receptor transcription pathway
MECANISMO DE DOENÇA

Adrenal hypoplasia, congenital

A disorder of adrenal gland development characterized by absence of the permanent zone of the adrenal cortex, structural disorganization of the adrenal glands, adrenal insufficiency and profound hormonal deficiencies. AHC patients manifest primary adrenal failure usually in early infancy, and hypogonadotropic hypogonadism leading to absent or incomplete sexual maturation. AHC can be inherited in an X-linked or autosomal recessive pattern.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
42.5 TPM
Testículo
39.1 TPM
Ovário
4.8 TPM
Pituitária
3.5 TPM
Cervix Ectocervix
2.9 TPM
OUTRAS DOENÇAS (5)
X-linked adrenal hypoplasia congenita46,XY sex reversal 246,XY complete gonadal dysgenesis46,XX testicular disorder of sex development
HGNC:7960UniProt:P51843

Variantes genéticas (ClinVar)

99 variantes patogênicas registradas no ClinVar.

🧬 DHH: GRCh38/hg38 12p13.33-q13.12(chr12:82453-49847230)x3 ()
🧬 DHH: NM_021044.4(DHH):c.680C>T (p.Ala227Val) ()
🧬 DHH: NM_021044.4(DHH):c.734G>C (p.Arg245Pro) ()
🧬 DHH: NM_021044.4(DHH):c.802A>G (p.Thr268Ala) ()
🧬 DHH: NM_021044.4(DHH):c.30del (p.Cys11fs) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

39 vias biológicas associadas aos genes desta condição.

Class B/2 (Secretin family receptors) Hedgehog ligand biogenesis Release of Hh-Np from the secreting cell Ligand-receptor interactions Hedgehog 'on' state Activation of SMO HHAT G278V doesn't palmitoylate Hh-Np Transcriptional regulation of testis differentiation Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol Synthesis of bile acids and bile salts via 24-hydroxycholesterol Synthesis of bile acids and bile salts via 27-hydroxycholesterol Retinoid metabolism and transport Factors involved in megakaryocyte development and platelet production Nuclear Receptor transcription pathway SUMOylation of intracellular receptors Transcriptional regulation of pluripotent stem cells MyD88:MAL(TIRAP) cascade initiated on plasma membrane FCERI mediated MAPK activation TRAF6 mediated NF-kB activation TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation MyD88 cascade initiated on plasma membrane rRNA modification in the nucleus and cytosol Major pathway of rRNA processing in the nucleolus and cytosol Oxidative Stress Induced Senescence SUMOylation of DNA damage response and repair proteins SUMOylation of transcription cofactors SUMOylation of chromatin organization proteins SUMOylation of RNA binding proteins SUMOylation of DNA methylation proteins RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known Regulation of PTEN gene transcription Negative Regulation of CDH1 Gene Transcription Nephron development Deactivation of the beta-catenin transactivating complex Transcriptional regulation by RUNX2 Transcriptional and post-translational regulation of MITF-M expression and activity Developmental Lineage of Pancreatic Acinar Cells Developmental Lineage of Pancreatic Ductal Cells Developmental Lineage of Multipotent Pancreatic Progenitor Cells

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Disgenesia gonadal completa 46,XY

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
32 papers (10 anos)

Mostrando amostra de 4 publicações de um total de 32

#1

46, XY Complete Gonadal Dysgenesis (Swyer Syndrome) Presenting as Primary Amenorrhea in a Normomorphic Adult Female From Kakamega, Kenya.

Clinical case reports2025 Jan

Differences/disorders of sex development (DSDs) are a diverse group of congenital conditions that result in disagreement between an individual's sex chromosomes, gonads, and/or anatomical sex. The 46, XY DSD group is vast and includes various conditions caused by genetic variants, hormonal imbalances, or abnormal sensitivity to testicular hormones, leading to varying degrees of under-virilization. A 19-year-old phenotypically normal female from Kakamega, Kenya, presented with primary amenorrhea. Physical examination revealed Tanner stage 3 breast development, Tanner stage 4 pubic hair, normal external genitalia, and a gynoid body shape. Hormonal profile tests indicated hypergonadotropic hypogonadism with normal 17-hydroxyprogesterone and testosterone levels. MRI revealed a hypoplastic uterus and absent ovaries. Karyotyping confirmed a 46, XY genotype, leading to the diagnosis of 46, XY complete gonadal dysgenesis (Swyer syndrome). Swyer syndrome is a rare disorder of sex development, characterized by unambiguous female genitalia, bilateral streak gonads, and elevated gonadotropin levels in individuals with a 46, XY karyotype. The condition results from abnormal gonadal development due to mutations in testis-determining factors, most commonly the SRY gene. Patients typically present with primary amenorrhea and seldom have secondary sexual characteristics as this patient had. Management includes hormone replacement therapy and gonadectomy because of the increased risk of gonadal tumors. The patient was educated about her condition, initiated on combined contraceptive pills, and counseled on exploratory laparoscopic gonadectomy. This case highlights the importance of a comprehensive diagnostic approach in patients with primary amenorrhea, keeping in mind that patients with disorders of sex development may have developed secondary sexual characteristics. The purpose of this overview is to: 1.. To describe the clinical characteristics of nonsyndromic disorders of testicular development; 2.. To review the genetic causes of nonsyndromic disorders of testicular development and conditions that may be in the differential diagnosis; 3.. To provide an evaluation strategy to identify the genetic cause of nonsyndromic disorders of testicular development (when possible); 4.. To inform management regarding sex of rearing, medical/surgical intervention (when appropriate), hormone therapy, and psychosocial aspects of care; 5.. To inform genetic risk assessment in family members of a proband.

#2

A case of late diagnosis and management of 46 XY complete gonadal dysgenesis in adulthood.

Ginekologia polska2021
#3

Novel pathogenic mutations in disorders of sex development associated genes cause 46,XY complete gonadal dysgenesis.

Gene2019 Nov 15

Disorders of sex development (DSDs) are congenital conditions in which chromosomal, gonadal and sex is atypical. It is difficult to diagnose and manage patients with DSD in clinical practice, and the molecular etiology of DSD is still not completely understood. Here, we identified two novel pathogenic mutations from three unrelated Chinese patients with 46,XY complete gonadal dysgenesis (CGD) that is a clinical subgroup of DSD by whole exome sequencing. A novel mutation in the SRY gene (c.161delG) was identified in the first patient, and the second patient carried a novel missense mutation in the MAP3K1 gene (c.2117T>G). Bioinformatics analysis found that the deletion of SRY (c.161delG) led to a premature stop codon at amino acid 59 in the SRY protein, which resulted in lacking the DNA binding domain of SRY protein. Functional studies found that the missense mutation in the MAP3K1 gene (c.2117T>G) could interfere with the gene function through increasing the phosphorylation of the downstream targets of MAP3K1, ERK1/2 and p38, which resulted in reducing testis-determining factor SOX9 expression and increasing ovary-promoting factor β-catenin activity. According to the American college of medical genetics and genomics (ACMG) standards and guidelines, these mutations were categorized as "pathogenic" mutations. Thus, our findings provide two novel pathogenic mutations associated with 46,XY CGD that can improve the etiological diagnosis for 46,XY CGD. ABBREVIATIONS.

#4

Functional Analysis of Mutations at Codon 127 of the SRY Gene Associated with 46,XY Complete Gonadal Dysgenesis.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation2017

Complete gonadal dysgenesis (CGD) is characterized by an incomplete differentiation of the genital organs in a patient with a 46,XY karyotype. It is induced by mutations in the sex-determining region Y (SRY) gene which plays a key role in testis-determining pathways. The aim of this study was to investigate the possible pathogenic nature of a novel SRY mutation (p.Y127H) identified in a 46,XY female patient. To determine the effect of this mutation on SRY function, we studied its impact on DNA interaction by electrophoretic mobility shift assays. Since tyrosine 127 is close to the C-terminal nuclear localization signal of SRY, we conducted HA-SRY protein expression to observe the impact of the mutation on the nuclear import function in transfected cells. Our results showed that the Y127H mutation nearly abolishes the DNA-binding capacity of SRY and strongly impairs the nuclear localization of the mutated protein. Together with a previously described mutation analyzed in parallel in this paper (p.Y127C), our results highlight this tyrosine residue as a crucial structural determinant of the high mobility group box domain. This is the first report to explain the molecular mechanism of the Y127H mutation causing sex reversal and gives new insights for clinical practice to benefit patients with disorders of sex development.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Disgenesia gonadal completa 46,XY.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Disgenesia gonadal completa 46,XY

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. 46, XY Complete Gonadal Dysgenesis (Swyer Syndrome) Presenting as Primary Amenorrhea in a Normomorphic Adult Female From Kakamega, Kenya.
    Clinical case reports· 2025· PMID 39839949mais citado
  2. A case of late diagnosis and management of 46 XY complete gonadal dysgenesis in adulthood.
    Ginekologia polska· 2021· PMID 34105736mais citado
  3. Novel pathogenic mutations in disorders of sex development associated genes cause 46,XY complete gonadal dysgenesis.
    Gene· 2019· PMID 31446095mais citado
  4. Functional Analysis of Mutations at Codon 127 of the SRY Gene Associated with 46,XY Complete Gonadal Dysgenesis.
    Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation· 2017· PMID 28787711mais citado
  5. STARD9 and CDK5RAP2-Novel Candidate Genes for 46,XY Complete Gonadal Dysgenesis.
    Int J Mol Sci· 2025· PMID 41373726recente
  6. Perspective on postoperative hormone replacement therapy and fertility preservation in Swyer syndrome with dysgerminoma: a case series and literature review.
    Eur J Obstet Gynecol Reprod Biol· 2026· PMID 41317609recente
  7. Isodicentric Y chromosome with SRY duplication in a female with complete gonadal dysgenesis.
    Mol Cytogenet· 2025· PMID 41029381recente
  8. Case report: Rare heterozygous variant in the NR5A1 gene causing 46,XY complete gonadal dysgenesis with a non-communicating rudimentary uterus.
    Front Med (Lausanne)· 2024· PMID 39149602recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:242(Orphanet)
  2. MONDO:0010765(MONDO)
  3. GARD:5068(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q957751(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Disgenesia gonadal completa 46,XY
Compêndio · Raras BR

Disgenesia gonadal completa 46,XY

ORPHA:242 · MONDO:0010765
Prevalência
Unknown
Herança
Autosomal dominant, Autosomal recessive, X-linked recessive, Y-linked
CID-10
Q99.1 · Hermafrodite verdadeiro 46, XX
CID-11
Início
Adolescent, Adult
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0018054
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades